吸入类固醇在处理特异性鼻炎的作用已被确认,相比之下,对非特异性鼻炎的作用却研究不足。作者对非特异性鼻炎病人每天用二丙酸倍氯米松(BDP)600μg,共12周,作为与安慰剂对照的长期双盲试验。规定选择常年性鼻炎病人有鼻塞、阵发性喷嚏、浆液粘液性鼻溢液存在。而对有季节性或特异性家族史、常见吸入性变应原皮试阳性、鼻息肉、鼻脓毒病、鼻中隔偏曲或X线鼻窦异常的病人除外。试验前4周停止所有治疗,入院后对鼻塞、前鼻孔溢液、后鼻孔溢液和面痛以0～5度分度作为症状基 The role of inhaled steroids in the treatment of specific rhinitis has been confirmed, in contrast, the role of non-specific rhinitis has not been studied. The authors used 600 μg of beclomethasone dipropionate (BDP) daily for 12 weeks in nonspecific rhinitis patients as a long-term, double-blind, placebo-controlled, double-blind trial. The provisions of perennial rhinitis patients with nasal congestion, paroxysmal sneeze, serous mucus nose exists. For patients with a seasonal or specific family history of common inhaled allergens skin test positive, nasal polyps, nasal sepsis, nasal septum deviation or abnormal X-ray sinus patients. Four weeks before the trial to stop all treatment, admission to the nasal obstruction, anterior nasal discharge, posterior nasal discharge and nocturnal to 0 to 5 degrees index as a symptom base